Grace Therapeutics, INC. (GRCE) SEC Filings — 2025

Filings

• Grace Therapeutics Amends 10-Q for Share Count Correction — 10-Q/A · Nov 17, 2025
• Grace Therapeutics Files 8-K — 8-K · Nov 13, 2025
• Grace Therapeutics Files 8-K — 8-K · Oct 23, 2025
• Grace Therapeutics Files 8-K — 8-K · Sep 18, 2025
• Grace Therapeutics Files 8-K on Shareholder Matters — 8-K · Sep 12, 2025
• Grace Therapeutics Files 8-K — 8-K · Aug 27, 2025
• Grace Therapeutics' Net Loss Widens to $5.2M Amid R&D Push — 10-Q · Aug 12, 2025
• Grace Therapeutics Sets Virtual Annual Meeting for Sept. 12 — DEF 14A · Jul 28, 2025
• Grace Therapeutics Files 8-K — 8-K · Jun 25, 2025
• Grace Therapeutics Maintains Nasdaq Listing, Compliance Status — 10-K · Jun 23, 2025
• Grace Therapeutics Files 8-K — 8-K · Apr 9, 2025
• Grace Therapeutics Files 8-K — 8-K · Mar 3, 2025
• Grace Therapeutics Files 10-Q/A for Q3 2024 — 10-Q/A · Feb 19, 2025
• Grace Therapeutics Files Q3 2024 10-Q — 10-Q · Feb 13, 2025
• Grace Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · Feb 10, 2025